Annual Cash & Cash Equivalents
$257.22 M
+$35.36 M+15.94%
31 December 2023
Summary:
PROCEPT BioRobotics annual cash & cash equivalents is currently $257.22 million, with the most recent change of +$35.36 million (+15.94%) on 31 December 2023. During the last 3 years, it has risen by +$157.09 million (+156.89%). PRCT annual cash & cash equivalents is now -15.48% below its all-time high of $304.32 million, reached on 31 December 2021.PRCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$196.76 M
-$17.33 M-8.10%
30 September 2024
Summary:
PROCEPT BioRobotics quarterly cash and cash equivalents is currently $196.76 million, with the most recent change of -$17.33 million (-8.10%) on 30 September 2024. Over the past year, it has dropped by -$90.33 million (-31.46%). PRCT quarterly cash and cash equivalents is now -38.60% below its all-time high of $320.48 million, reached on 30 September 2021.PRCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRCT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.9% | -31.5% |
| 3 y3 years | +156.9% | -38.6% |
| 5 y5 years | - | - |
PRCT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.5% | +156.9% | -38.6% | +31.4% |
| 5 y | 5 years | -15.5% | +512.1% | -38.6% | +96.5% |
| alltime | all time | -15.5% | +512.1% | -38.6% | +96.5% |
PROCEPT BioRobotics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $196.76 M(-8.1%) |
| June 2024 | - | $214.09 M(-5.1%) |
| Mar 2024 | - | $225.58 M(-12.3%) |
| Dec 2023 | $257.22 M(+15.9%) | $257.22 M(-10.4%) |
| Sept 2023 | - | $287.09 M(+91.8%) |
| June 2023 | - | $149.69 M(-17.3%) |
| Mar 2023 | - | $180.97 M(-18.4%) |
| Dec 2022 | $221.86 M | $221.86 M(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $249.22 M(-7.6%) |
| June 2022 | - | $269.81 M(-5.1%) |
| Mar 2022 | - | $284.29 M(-6.6%) |
| Dec 2021 | $304.32 M(+203.9%) | $304.32 M(-5.0%) |
| Sept 2021 | - | $320.48 M(+101.3%) |
| June 2021 | - | $159.22 M(+59.0%) |
| Dec 2020 | $100.13 M(+138.3%) | $100.13 M |
| Dec 2019 | $42.02 M | - |
FAQ
- What is PROCEPT BioRobotics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics annual cash & cash equivalents year-on-year change?
- What is PROCEPT BioRobotics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics quarterly cash and cash equivalents year-on-year change?
What is PROCEPT BioRobotics annual cash & cash equivalents?
The current annual cash & cash equivalents of PRCT is $257.22 M
What is the all time high annual cash & cash equivalents for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high annual cash & cash equivalents is $304.32 M
What is PROCEPT BioRobotics annual cash & cash equivalents year-on-year change?
Over the past year, PRCT annual cash & cash equivalents has changed by +$35.36 M (+15.94%)
What is PROCEPT BioRobotics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRCT is $196.76 M
What is the all time high quarterly cash and cash equivalents for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high quarterly cash and cash equivalents is $320.48 M
What is PROCEPT BioRobotics quarterly cash and cash equivalents year-on-year change?
Over the past year, PRCT quarterly cash and cash equivalents has changed by -$90.33 M (-31.46%)